RSS-Feed abonnieren
DOI: 10.1055/s-0045-1805082
Evaluation of Radiotherapy Practice in Patients Aged over 80: A Retrospective Study
Abstract
Background
The study aims to evaluate the survival outcomes, survival-related prognostic factors, and treatment compliance in cancer patients aged ≥80 years treated with radiotherapy (RT).
Methods
The records of 76 patients who received RT at a single center between August 2021 and May 2024 were retrospectively evaluated. Patient and tumor characteristics and treatment details were collected from medical records.
Results
The median age of the patients was 83 years (range: 80–92 years). According to the purpose of RT, palliative (53.8%), definitive (18.4%), and adjuvant (15.8%) RT were most frequently administered, respectively. The median overall survival (OS) in all patients was 10 months. The median OS in patients receiving curative (definitive and adjuvant RT) and palliative RT was 25.1 and 7.2 months, respectively. Poor performance status (PS), leukocyte count prior to RT, compliance, and hospitalization status in the curative group and poor PS, RT compliance, hospitalization status, and new distant recurrence in the palliative group were associated with decreased OS. The majority of patients showed full compliance with the RT process (69.7%). The rate of full compliance with the treatment process was significantly higher in patients with good PS and receiving outpatient treatment. RT-related high-grade toxicity (grade 3–4) was not observed.
Conclusion
This study demonstrates that RT can be used effectively and safely for both palliative and curative purposes in cancer patients aged ≥80 years. The optimization of patient selection and ultimately improvement of treatment outcomes will be facilitated by the support of these results with multicenter studies.
Authors' Contributions
The concept and design of the study were developed by H.D., İ.B., İ.A., M.C.K. Acquisition and analysis of data were done by H.D., İ.B., and İ.A. Drafting of the manuscript was done by H.D., İ.B., and M.C.K. Critical review of the manuscript was done by H.D., İ.B., İ.A., and M.C.K.
Publikationsverlauf
Eingereicht: 27. Januar 2025
Angenommen: 06. Februar 2025
Artikel online veröffentlicht:
07. März 2025
© 2025. MedIntel Services Pvt Ltd. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India
-
References
- 1 WHO. . World Report on Ageing and Health 2015 . Accessed August 1, 2023 at: https://apps.who.int/iris/handle/10665/186463
- 2 WHO. . World Population Prospects 2022: Summary of Results. United Nations Department of Economic and Social Affairs, Population Division. Accessed January 25, 2022 at: https://www.un.org/development/desa/pd/sites/www.un.org.development.desa.pd/files/wpp2022_summary_of_results.pdf
- 3 TÜİK. . Genel Nüfus Sayımları, 1935–2000 TÜİK, Adrese Dayalı Nüfus Kayıt Sistemi, 2008–2019 TÜİK, Nüfus Projeksiyonları, 2023–2080
- 4 Howlander N, Noone AM, Krapcho M. et al SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute; 1975. –2012
- 5 Savaş TUNA. Kanserli geriatrik hastalarda komorbidite ve klinik de¤erlendirme. Türk Onkoloji Dergisi 2007; 22 (04) 192-196
- 6 Pilleron S, Soto-Perez-de-Celis E, Vignat J. et al. Estimated global cancer incidence in the oldest adults in 2018 and projections to 2050. Int J Cancer 2021; 148 (03) 601-608
- 7 Oken MM, Creech RH, Tormey DC. et al. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5 (06) 649-655
- 8 U.S. Department of Health and Human Services. Common Terminology Criteria for Adverse Events (CTCAE). Washington, DC: U.S. Department of Health and Human Services; 2017
- 9 Khan HTA. Population ageing in a globalized world: risks and dilemmas?. J Eval Clin Pract 2019; 25 (05) 754-760
- 10 Roeder F, Jensen AD, Lindel K, Mattke M, Wolf F, Gerum S. Geriatric radiation oncology: what we know and what can we do better?. Clin Interv Aging 2023; 18: 689-711
- 11 DeSantis CE, Miller KD, Dale W. et al. Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin 2019; 69 (06) 452-467
- 12 Katano A, Yamashita H. Radiotherapy in nonagenarian patients: a 20-year retrospective analysis in a single ternary centre. J Med Imaging Radiat Oncol 2024; 68 (01) 103-109
- 13 Nguyen NP, Godinez J, Shen W. et al. International Geriatric Radiotherapy Group. Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?. Medicine (Baltimore) 2016; 95 (43) e5212
- 14 Popescu T, Karlsson U, Vinh-Hung V. et al; Challenges facing radiation oncologists in the management of older cancer patients: consensus of the International Geriatric Radiotherapy Group. Cancers (Basel) 2019; 11 (03) 371
- 15 Ikeda H, Ishikura S, Oguchi M. et al. Analysis of 57 nonagenarian cancer patients treated by radical radiotherapy: a survey of eight institutions. Jpn J Clin Oncol 1999; 29 (08) 378-381
- 16 Kocik L, Geinitz H, Track C, Geier M, Nieder C. Feasibility of radiotherapy in nonagenarian patients: a retrospective study. Strahlenther Onkol 2019; 195 (01) 62-68